This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merrell, K.
Right arrow Articles by Calame, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merrell, K.
Right arrow Articles by Calame, K.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 06 1997, 3335-3344, Vol 17, No. 6
Copyright © 1997, American Society for Microbiology

The absence of the transcription activator TFE3 impairs activation of B cells in vivo

K Merrell, S Wells, A Henderson, J Gorman, F Alt, A Stall and K Calame
Integrated Program in Cellular, Molecular and Biophysical Studies, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

TFE3 is a ubiquitously expressed member of the TFE3/mi family of basic helix loop helix zipper transcription factors. TFE3 binds to muE3 sites located in the immunoglobulin heavy-chain (IgH) intronic enhancer, heavy-chain variable region promoters, the Ig kappa intronic enhancer, and regulatory sites in other genes. To understand the role of TFE3 in Ig expression and lymphoid development, we used embryonic stem (ES) cell-mediated gene targeting and RAG2-/- blastocyst complementation to generate mice which lack TFE3 in their B and T lymphocytes. TFE3- ES cells fully reconstitute the B- and T-cell compartments, giving rise to normal patterns of IgM+ B220+ B cells and CD4+ and CD8+ T cells. However, TFE3- B cells show several defects consistent with poor B-cell activation. Serum IgM levels are reduced twofold and IgG and IgA isotypes are reduced three- to sixfold in the TFE3- chimeras even though in vitro, the TFE3- splenocytes secrete normal levels of all isotypes in response to lipopolysaccharide activation. Peripheral TFE3- B cells also show reduced surface expression of CD23 and CD24 (heat- stable antigen).


This article has been cited by other articles:

  • Kuiper, R. P., Schepens, M., Thijssen, J., Schoenmakers, E. F. P. M., van Kessel, A. G. (2004). Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res 32: 2315-2322 [Abstract] [Full Text]  
  • McCarthy, K. M., McDevit, D., Andreucci, A., Reeves, R., Nikolajczyk, B. S. (2003). HMGA1 Co-activates Transcription in B Cells through Indirect Association with DNA. J. Biol. Chem. 278: 42106-42114 [Abstract] [Full Text]  
  • Steingrimsson, E., Tessarollo, L., Pathak, B., Hou, L., Arnheiter, H., Copeland, N. G., Jenkins, N. A. (2002). Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc. Natl. Acad. Sci. USA 99: 4477-4482 [Abstract] [Full Text]  
  • Tian, G., Erman, B., Ishii, H., Gangopadhyay, S. S., Sen, R. (1999). Transcriptional Activation by ETS and Leucine Zipper-Containing Basic Helix-Loop-Helix Proteins. Mol. Cell. Biol. 19: 2946-2957 [Abstract] [Full Text]  
  • Weilbaecher, K. N., Hershey, C. L., Takemoto, C. M., Horstmann, M. A., Hemesath, T. J., Tashjian, A. H. Jr., Fisher, D. E. (1998). Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3. JEM 187: 775-785 [Abstract] [Full Text]  
  • Erman, B., Cortes, M., Nikolajczyk, B. S., Speck, N. A., Sen, R. (1998). ETS-Core Binding Factor: a Common Composite Motif in Antigen Receptor Gene Enhancers. Mol. Cell. Biol. 18: 1322-1330 [Abstract] [Full Text]